Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Watchlist
Price: 4.4 HKD -2.87% Market Closed
Market Cap: 19.9B HKD
Have any thoughts about
Shandong Weigao Group Medical Polymer Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Shandong Weigao Group Medical Polymer Co Ltd stock under the Base Case scenario is 9 HKD. Compared to the current market price of 4.4 HKD, Shandong Weigao Group Medical Polymer Co Ltd is Undervalued by 51%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
9 HKD
Undervaluation 51%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Shandong Weigao Group Medical Polymer Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Shandong Weigao Group Medical Polymer Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Shandong Weigao Group Medical Polymer Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Shandong Weigao Group Medical Polymer Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Shandong Weigao Group Medical Polymer Co Ltd

Provide an overview of the primary business activities
of Shandong Weigao Group Medical Polymer Co Ltd.

What unique competitive advantages
does Shandong Weigao Group Medical Polymer Co Ltd hold over its rivals?

What risks and challenges
does Shandong Weigao Group Medical Polymer Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide P/S
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide P/E
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide P/OCF
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide P/FCFE
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide P/B
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide EV/S
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide EV/GP
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide EV/EBITDA
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide EV/EBIT
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide EV/OCF
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide EV/FCFF
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide EV/IC
for Shandong Weigao Group Medical Polymer Co Ltd.

Show me price targets
for Shandong Weigao Group Medical Polymer Co Ltd made by professional analysts.

What are the Revenue projections
for Shandong Weigao Group Medical Polymer Co Ltd?

How accurate were the past Revenue estimates
for Shandong Weigao Group Medical Polymer Co Ltd?

What are the Net Income projections
for Shandong Weigao Group Medical Polymer Co Ltd?

How accurate were the past Net Income estimates
for Shandong Weigao Group Medical Polymer Co Ltd?

What are the EPS projections
for Shandong Weigao Group Medical Polymer Co Ltd?

How accurate were the past EPS estimates
for Shandong Weigao Group Medical Polymer Co Ltd?

What are the EBIT projections
for Shandong Weigao Group Medical Polymer Co Ltd?

How accurate were the past EBIT estimates
for Shandong Weigao Group Medical Polymer Co Ltd?

Compare the revenue forecasts
for Shandong Weigao Group Medical Polymer Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shandong Weigao Group Medical Polymer Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shandong Weigao Group Medical Polymer Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shandong Weigao Group Medical Polymer Co Ltd compared to its peers.

Compare the P/E ratios
of Shandong Weigao Group Medical Polymer Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Shandong Weigao Group Medical Polymer Co Ltd with its peers.

Analyze the financial leverage
of Shandong Weigao Group Medical Polymer Co Ltd compared to its main competitors.

Show all profitability ratios
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide ROE
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide ROA
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide ROIC
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide ROCE
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide Gross Margin
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide Operating Margin
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide Net Margin
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide FCF Margin
for Shandong Weigao Group Medical Polymer Co Ltd.

Show all solvency ratios
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide D/E Ratio
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide D/A Ratio
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide Interest Coverage Ratio
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide Altman Z-Score Ratio
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide Quick Ratio
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide Current Ratio
for Shandong Weigao Group Medical Polymer Co Ltd.

Provide Cash Ratio
for Shandong Weigao Group Medical Polymer Co Ltd.

What is the historical Revenue growth
over the last 5 years for Shandong Weigao Group Medical Polymer Co Ltd?

What is the historical Net Income growth
over the last 5 years for Shandong Weigao Group Medical Polymer Co Ltd?

What is the current Free Cash Flow
of Shandong Weigao Group Medical Polymer Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shandong Weigao Group Medical Polymer Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shandong Weigao Group Medical Polymer Co Ltd

Current Assets 19.5B
Cash & Short-Term Investments 7.9B
Receivables 8B
Other Current Assets 3.7B
Non-Current Assets 15B
Long-Term Investments 2.1B
PP&E 7.3B
Intangibles 5.1B
Other Non-Current Assets 474.4m
Current Liabilities 6B
Accounts Payable 4.7B
Other Current Liabilities 1.2B
Non-Current Liabilities 5.5B
Long-Term Debt 3.5B
Other Non-Current Liabilities 2.1B
Efficiency

Earnings Waterfall
Shandong Weigao Group Medical Polymer Co Ltd

Revenue
13B CNY
Cost of Revenue
-6.5B CNY
Gross Profit
6.5B CNY
Operating Expenses
-4B CNY
Operating Income
2.5B CNY
Other Expenses
-557.2m CNY
Net Income
1.9B CNY

Free Cash Flow Analysis
Shandong Weigao Group Medical Polymer Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shandong Weigao Group Medical Polymer Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive Net Income
57/100
Profitability
Score

Shandong Weigao Group Medical Polymer Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shandong Weigao Group Medical Polymer Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
69/100
Solvency
Score

Shandong Weigao Group Medical Polymer Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shandong Weigao Group Medical Polymer Co Ltd

Wall Street analysts forecast Shandong Weigao Group Medical Polymer Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Weigao Group Medical Polymer Co Ltd is 6.79 HKD with a low forecast of 5.15 HKD and a high forecast of 8.4 HKD.

Lowest
Price Target
5.15 HKD
17% Upside
Average
Price Target
6.79 HKD
54% Upside
Highest
Price Target
8.4 HKD
91% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Shandong Weigao Group Medical Polymer Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shandong Weigao Group Medical Polymer Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd

Country

China

Industry

Health Care

Market Cap

20.1B HKD

Dividend Yield

4.65%

Description

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Weihai, Shandong. The company went IPO on 2004-02-27. The firm sells products under brand names of Jierui and Wego Ortho. The firm operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The firm is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.

Contact

SHANDONG
Weihai
No.18 Xingshan Road,Torch Hi-Tech Industry Development Zone
+866315621999.0
www.weigaoholding.com

IPO

2004-02-27

Employees

10 792

Officers

Executive Chairman of the Board & Compliance Officer
Mr. Jing Long
Chief Executive Officer
Mr. Rinan Cong
Chief Financial Officer
Mr. Xue Feng Wu
Non-Executive Director
Ms. Xia Yan
Executive Director
Mr. Daoming Wang
Company Secretary
Ms. Miu Ling Wong ACIS, FCIS, FCS

See Also

Discover More
What is the Intrinsic Value of one Shandong Weigao Group Medical Polymer Co Ltd stock?

The intrinsic value of one Shandong Weigao Group Medical Polymer Co Ltd stock under the Base Case scenario is 9 HKD.

Is Shandong Weigao Group Medical Polymer Co Ltd stock undervalued or overvalued?

Compared to the current market price of 4.4 HKD, Shandong Weigao Group Medical Polymer Co Ltd is Undervalued by 51%.

Back to Top